Urology Board Reviews
1 - 2 of 2 results
The BoardVitals Urology CME Review offers clinicians 40 AMA PRA Category 1 CreditsTM and over 700 Urology board review questions. The questions cover key topics including bladder cancer, bladder dysfunction, and infertility. This question bank will assist clinicians with Urology certification and recertification.
The BoardVitals Urology CME Review also features:
- Quick and Convenient CME
- Computer, phone, and tablet access
- Constantly updated up-to-date questions
- Questions that are targeted specifically to the exam
- Online CME tracker
- 100% Pass Guarantee
- Statistical comparison to other Urology test-takers (Nationally)
After completing this activity, you should be able to:
- Diagnose common and rare disorders which may be encountered in Urology.
- Order and interpret results of common laboratory tests in Urology.
- Describe the range of available treatments and essential concepts in the field of Urology
Target Audience: UrologistsSee full details chevron_right
- Cost: $599
- Credit hours: 40
- CME credits awarded by: BoardVitals
- Format: On-Demand Online
- Material last updated: Continuously Updated
- SAVE 15% W/ CODE: CME15
Continuing Medical Education: Advances in Urology
Comprehensive Review of Urology provides current, relevant information on adult and pediatric disorders of the male and female urinary tract, the male reproductive system, and the kidney. Led by renowned urologist Aria F. Olumi, MD, lecturers use guideline-driven information that will improve your approach to screening, staging, diagnosis, and treatment. You’ll get expert take-home points from each lecture, including:
- MRI of Prostate Cancer. MRI is effective in detecting focal areas of highgrade prostate cancer, providing accurate locoregional staging, and guiding targeted biopsies.
- Kidney Cancer – Laparoscopic Management. Laparoscopic and robotic nephrectomy is now the standard care for most renal cell carcinoma patients. It offers significant advantages in morbidity while maintaining oncologic outcomes of open surgery.
- The Etiology and Treatment of Pelvic Organ Prolapse. Vaginal wall descent is a normal part of aging; however, once the bulge protrudes past the hymen, most women are symptomatic.
- Surgical Management of Muscle Invasive Bladder Cancer. Surgical management of high-risk bladder cancer is a central component of definitive treatment. Wide resection of the bladder/perivesical tissues and control of the regional pelvic lymph nodes are key surgical tenets.
At the conclusion of this CME activity, you will be better able to:
- Discuss appropriate imaging for disorders of the prostate
- Explain the therapeutic approaches to recurrent urinary tract infections
- Describe office care and surgical approaches for transgender patients
- Define the diagnostic approach to a patient suspected of having penile cancer
- Explain the initial surgical approach to a patient with bladder trauma
- Distinguish between medical and surgical management of urinary lithiasis
- Compare the advantages of open surgical management and laparoscopic management for kidney cancer
- Differentiate which patients are appropriate for surgical management of urinary continence and which are appropriate for medical management
- Identify the best patient population for active surveillance of prostate cancer
- Explain the causes of urinary tract infections in children
- Summarize the neurogenic bladder issues in the adult spina bifida patient
The activity was designed to provide urologists, urology fellows and residents, surgery residents interested in urology, other licensed individual practitioners or ancillary staff interested in urology, or who participate in the delivery of urologic care with current, relevant, and condensed information needed to pass certification and recertification exams.See full details chevron_right
- Cost: $1095
- Credit hours: 62
- CME credits awarded by: Oakstone Publishing, LLC
- Format: On-Demand Online, Online Video, Online Audio, Audio CD
- Material last updated: March 15, 2021
- Expiration of CME credit: March 15, 2024